drugdeliverybusiness1h
Senseonics to consider reverse stock split, reports strong Eversense 365 interest
Senseonics (NYSE:SENS) announced preliminary financial results for 2024 as it considers a reverse stock split.
drugdeliverybusiness22h
Hedia, Glooko launch personalized bolus insulin dosing tech
Glooko and Hedia announced today that launched their interoperable solution for advanced bolus insulin dosing support.
drugdeliverybusiness1d
Phillips Medisize enhances inhaled drug delivery portfolio with Vectura acquisition
Phillips Medisize parent company Molex has completed its acquisition of Vectura from a subsidiary of cigarette maker Philip ...
drugdeliverybusiness2d
Beta Bionics is proposing an IPO
Beta Bionics announced today that it filed a registration statement with the SEC relating to a proposed initial public ...
drugdeliverybusiness2d
Tandem inks collab with UVA to develop closed-loop automated insulin delivery tech
Tandem Diabetes Care (Nasdaq:TNDM) announced today that it signed a multi-year R&D collaboration agreement with the ...
drugdeliverybusiness2d
CeQur raises $120M to support insulin delivery tech
CeQur announced today that it closed a $120 million financing round to support its wearable insulin delivery technology.
drugdeliverybusiness5d
PreEvnt to unveil non-invasive blood glucose alert device
The Isaac blood glucose alert device. [Image courtesy of PreEvnt] PreEvnt recently announced plans to introduce Isaac, its non-invasive alert device for monitoring blood glucose levels. Isaac, which ...